European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global: Annual Meeting 2025 Highlights
Description
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global: Annual Meeting 2025 Highlights
Summary
ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID).
ESCMID Global 2025 took place in Vienna, Austria between April 11-15, 2025.
GlobalData remotely attended a number of scientific sessions where key therapies were featured, the contents of which were analyzed to create this ESCMID Global 2025 Highlights report.
Scope
Indications, companies, and therapies discussed
Gram-negative bacterial infections
Shionogi - Fetroja (cefiderocol)
Genital herpes
Assembly Biosciences - ABI-5366
Respiratory syncytial virus (RSV)
GSK - Arexvy (RSVPreF3 OA)
Gonorrhea
GSK - Blujepa (gepotidacin)
Lyme borreliosis
Valneva/Pfizer - VLA15
Mpox
Moderna - mRNA-1769
Cholera
Harvard Medical School - PanChol
Group B streptococcus
MinervaX - MVX0006
Reasons to Buy
This powerpoint-based deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Lyme borreliosis, RSV, mpox, gonorrhea, cholera, and more.
Inside the report you’ll find -
Summary
ESCMID Global is the annual congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (formerly ECCMID).
ESCMID Global 2025 took place in Vienna, Austria between April 11-15, 2025.
GlobalData remotely attended a number of scientific sessions where key therapies were featured, the contents of which were analyzed to create this ESCMID Global 2025 Highlights report.
Scope
Indications, companies, and therapies discussed
Gram-negative bacterial infections
Shionogi - Fetroja (cefiderocol)
Genital herpes
Assembly Biosciences - ABI-5366
Respiratory syncytial virus (RSV)
GSK - Arexvy (RSVPreF3 OA)
Gonorrhea
GSK - Blujepa (gepotidacin)
Lyme borreliosis
Valneva/Pfizer - VLA15
Mpox
Moderna - mRNA-1769
Cholera
Harvard Medical School - PanChol
Group B streptococcus
MinervaX - MVX0006
Reasons to Buy
This powerpoint-based deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Lyme borreliosis, RSV, mpox, gonorrhea, cholera, and more.
Inside the report you’ll find -
- Emerging trends in prophylactic or therapeutic strategies for the management of viral, and bacterial infections
- Insights into the disease areas and key sponsors that took precedence at the conference
- Key takeaways from headline sessions and late-breaking data
- Clinical and commercial implications of notable presentations
Table of Contents
20 Pages
- 1. Introduction
- 1.1. Contents
- 1.2. Abbreviations
- 2. Conference Overview - Key Indications and Sponsors
- 3. Conference Overview - Top Sponsors
- 4. Key Presentations
- 4.1. Gram-Negative Bacterial Infections
- 4.2. Genital Herpes
- 4.3. Respiratory Syncytial Virus (RSV)
- 4.4. Gonorrhea
- 4.5. Lyme Borreliosis
- 4.6. Mpox
- 4.7. Cholera
- 4.8. Group B Streptococcus
- 5. Appendix
- 5.1. About the Authors
- 6. Contact Us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


